Sareum (LON:SAR) Shares Pass Above 50 Day Moving Average – What’s Next?

Sareum Holdings plc (LON:SAR) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 22.85 and traded as high as GBX 29. Sareum shares last traded at GBX 28, with a volume of 838,407 shares traded.

Sareum Trading Down 2.8%

The firm has a 50-day moving average of GBX 22.95 and a 200 day moving average of GBX 19.92. The stock has a market capitalization of £39.08 million, a price-to-earnings ratio of -7.23 and a beta of -1.08.

Sareum Company Profile

Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.
Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms.